Celebrex Has No Apparent MI Signal At 200 Mg Or Less, FDAer Graham Says
This article was originally published in The Pink Sheet Daily
Executive Summary
The drug safety officer's meta-analysis suggests that Celebrex and Bextra can both be safely marketed at low doses, but Vioxx poses a risk at both the 25 mg and 50 mg doses. At committee meeting, Graham discusses results of two unpublished studies, which he says he was initially told by FDA not to present.